HALO logo

Halozyme Therapeutics, Inc. (HALO) EV/EBITDA

EV/EBITDA:

12.06-0.21(-1.71%)
September 4, 2025

Summary

  • As of today (September 5, 2025), HALO EV/EBITDA is 12.06, with a fall of -0.21 (-1.71%) during the most recent trading session on September 4, 2025.
  • Over the past year, HALO EV/EBITDA has dropped by -4.96 (-29.14%).
  • HALO EV/EBITDA is now -99.62% below its all-time high of 3171.43.

Performance

HALO EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherHALOvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

HALO EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday-1.7%-1.7%-1.9%
1 m1 month+19.8%+19.7%+22.4%
3 m3 months+14.9%+29.1%+36.3%
6 m6 months-2.5%+17.5%+26.3%
ytdytd+16.0%+39.8%+53.5%
1 y1 year-29.1%+7.9%+18.1%
5 y5 years+106.3%+151.1%+165.0%

HALO EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month12.27-1.7%10.07+19.8%
3 m3-month12.27-1.7%8.94+34.9%
6 m6-month13.69-11.9%8.94+34.9%
1 y1-year17.21-29.9%8.94+34.9%
3 y3-year31.91-62.2%8.94+34.9%
5 y5-year134.51-91.0%-194.44+106.2%
alltimeall time3171.43-99.6%-205.45+105.9%

HALO EV/EBITDA History

DateValue
2025
12.06(+16.0%)
2024
10.40(-19.6%)
2023
12.94(-53.8%)
2022
28.00(+28.0%)
2021
21.87(-42.3%)
2020
37.89(-189.1%)
2019
-42.53(+33.7%)
2018
-31.82(-203.9%)
2017
30.62(-288.4%)
2016
-16.25(-80.9%)
DateValue
2015
-85.29(+361.8%)
2014
-18.47(-13.9%)
2013
-21.46(+63.8%)
2012
-13.10(-73.9%)
2011
-50.13(+270.8%)
2010
-13.52(+70.3%)
2008
-7.94(-52.0%)
2007
-16.55(-50.1%)
2006
-33.19(+389.5%)
2005
-6.78

FAQ

  • What is Halozyme Therapeutics, Inc. EV/EBITDA?
  • What is the all time high EV/EBITDA for Halozyme Therapeutics, Inc.?
  • What is HALO EV/EBITDA year-to-date change?
  • What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?

What is Halozyme Therapeutics, Inc. EV/EBITDA?

The current EV/EBITDA of HALO is 12.06

What is the all time high EV/EBITDA for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high EV/EBITDA is 3171.43

What is HALO EV/EBITDA year-to-date change?

Halozyme Therapeutics, Inc. EV/EBITDA has changed by +1.66 (+15.96%) since the beginning of the year

What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?

Over the past year, HALO EV/EBITDA has changed by -4.96 (-29.14%)
On this page